{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:44:31Z","timestamp":1790286271611,"version":"4.1.0"},"reference-count":330,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The World Journal of Biological Psychiatry"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.3109\/15622975.2011.561872","type":"journal-article","created":{"date-parts":[[2011,4,12]],"date-time":"2011-04-12T09:52:32Z","timestamp":1302601952000},"page":"160-187","source":"Crossref","is-referenced-by-count":87,"title":["The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Substance Use and Related Disorders. Part 2: Opioid dependence"],"prefix":"10.1080","volume":"12","author":[{"given":"Michael","family":"Soyka","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Ludwig-Maximilian University, Munich, Germany"},{"name":"Private Hospital Meiringen, Meiringen, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry R.","family":"Kranzler","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"van den Brink","sequence":"additional","affiliation":[{"name":"Amsterdam Institute for Addiction Research and Department of Psychiatry of the Academic Medical Center University of Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Krystal","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Yale University School of Medicine, Yale-New Haven Hospital, New Haven, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-J\u00fcrgen","family":"M\u00f6ller","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Ludwig-Maximilian University, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegfried","family":"Kasper","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Medical University of Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The WFSBP Task Force on Treatment, Guidelines for Substance Use Disorders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2011,4,12]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2009.10399776"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta11060"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-0978"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-009-9105-4"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.09.012"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050559"},{"issue":"1","key":"e_1_3_2_8_1","first-page":"S6","article-title":"Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users","volume":"60","author":"Amass L","year":"2000","unstructured":"Amass L, Kamien JB, Reiber C, Branstetter S. 2000. Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users. Drug Alcohol Depend 60(Suppl 1):S6.","journal-title":"Drug Alcohol Depend"},{"key":"e_1_3_2_9_1","first-page":"CD004147","article-title":"Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence","author":"Amato L","year":"2008","unstructured":"Amato L, Minozzi S, Davoli M, Vecchi S, Ferri M, Mayet S. 2008a. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database Syst Rev:CD004147.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_10_1","first-page":"CD005031","article-title":"Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification","author":"Amato L","year":"2008","unstructured":"Amato L, Minozzi S, Davoli M, Vecchi S, Ferri M, Mayet S. 2008b. Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification. Cochrane Database Syst Rev:CD005031. DOI: 005010.001002\/14651858. CD14005031.pub14651853.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_11_1","first-page":"4","article-title":"Treatment of Patients with Substance Use Disorders, Second edition","volume":"164","author":"American Psychiatric Association Practice Guidelines","year":"2007","unstructured":"American Psychiatric Association Practice Guidelines. 2007. Treatment of Patients with Substance Use Disorders, Second edition. Am J Psychiatry 164:4(Suppl).","journal-title":"Am J Psychiatry"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952998909092720"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.11.024"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.1.39"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199806000-00016"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1159\/000067733"},{"key":"e_1_3_2_17_1","first-page":"161","article-title":"Das QT-Intervall w\u00e4hrend der Substitutionsbehandlung Heroinabh\u00e4ngiger [in German]","volume":"7","author":"Backmund M","year":"2005","unstructured":"Backmund M, Henkel C, Jordan F, Habsch J, Meyer K, K\u00e4\u00e4b S. 2005a. Das QT-Intervall w\u00e4hrend der Substitutionsbehandlung Heroinabh\u00e4ngiger [in German]. Suchtmed 7:161\u2013164.","journal-title":"Suchtmed"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1300\/J069v24n04_02"},{"key":"e_1_3_2_19_1","first-page":"176","article-title":"The risk of emergency treatment due to overdose in injection users","volume":"89","author":"Backmund M","year":"2009","unstructured":"Backmund M, Sch\u00fctz C, Mayer K, Edlin BR, Reimer J 2009. The risk of emergency treatment due to overdose in injection users. J Addict Dis 89:176\u2013182.","journal-title":"J Addict Dis"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/15622970802465807"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2001.9656834.x"},{"key":"e_1_3_2_22_1","first-page":"108","article-title":"Impact of slow-release oral morphine on drug abusing habits in Austria (in German)","volume":"24","author":"Beer B","year":"2010","unstructured":"Beer B, Rabl W, Libiseller K, Giacomuzzi S, Riemer Y, Pavlic M. 2010. Impact of slow-release oral morphine on drug abusing habits in Austria (in German). Neuropsychiatry 24:108\u2013117.","journal-title":"Neuropsychiatry"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200204000-00017"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/3527601465"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161209788168100"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130051096"},{"key":"e_1_3_2_27_1","first-page":"80","article-title":"Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department","volume":"29","author":"Binder T","year":"2008","unstructured":"Binder T, Vavrinkova B. 2008. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department. Neuroendocrinol Lett 29:80\u201386.","journal-title":"Neuroendocrinol Lett"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2009.02754.x"},{"issue":"2","key":"e_1_3_2_29_1","first-page":"5105","article-title":"Heroin-assisted treatment in the Netherlands: History, findings, and international context","volume":"20","author":"Blanken P","year":"2010","unstructured":"Blanken P, van den Brink W, Hendriks VM, Huijsman IA, Klous MG, Rook EJ, . 2010. Heroin-assisted treatment in the Netherlands: History, findings, and international context. Eur Neuropsychopharmacology 20(Suppl 2):5105\u20135158.","journal-title":"Eur Neuropsychopharmacology"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.16.9608"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2010.03052.x"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2001.116793"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/13556210410001674130"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/00952990802585406"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbl003"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-1600.2010.00274.x"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2009.02633.x"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826089609045806"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.3109\/10550499508997424"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.58.8.755"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/00952990903108215"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1981.01780360089010"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-1600.2009.00184.x"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2008.10.008"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2010.03120.x"},{"key":"e_1_3_2_46_1","first-page":"CD001088","article-title":"Psychosocial intervetions for people with both severe mental illness and substance misuse","volume":"23","author":"Cleary M","year":"2008","unstructured":"Cleary M, Hunt G, Matheson S, Siegfried N, Walter G. 2008. Psychosocial intervetions for people with both severe mental illness and substance misuse. Cochrane Database Syst Rev 23:CD001088.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1998.9310155913.x"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.8.903"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.2.210"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.08.005"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/0740-5472(91)90040-H"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta11090"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.630"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(97)00020-2"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2005.08.011"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2006.09.012"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2008.07.009"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000628"},{"key":"e_1_3_2_59_1","author":"Dahan A","year":"2006","unstructured":"Dahan A. 2006. Opioid-induced respiratory effects: new data on burprenorphine.","journal-title":"Opioid-induced respiratory effects: new data on burprenorphine"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/ael051"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e3181c38c25"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1093\/jurban\/jtg022"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2002.00214.x"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2000.9556874.x"},{"key":"e_1_3_2_65_1","volume-title":"Mortality amongst illicit drug users. Epidemiology, causes and intervention","author":"Darke S","year":"2007","unstructured":"Darke S, Degenhardt L, Mattick R. 2007. Mortality amongst illicit drug users. Epidemiology, causes and intervention. Cambridge: Cambridge University Press."},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(03)00146-9"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(02)00012-1"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004580.pub2"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2004.00959.x"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1159\/000018936"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1300\/J069v20n04_02"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1080\/09595230701711157"},{"key":"e_1_3_2_73_1","first-page":"277","article-title":"Residential therapeutic communities for female substance abusers","volume":"67","author":"De Leon G","year":"1991","unstructured":"De Leon G, Jainchill N 1991. Residential therapeutic communities for female substance abusers. Bull NY Acad Med 67:277\u2013290.","journal-title":"Bull NY Acad Med"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2005.08.002"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.01232.x"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.schbul.a033464"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2007.01.011"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.06111851"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241140-00003"},{"key":"e_1_3_2_80_1","volume-title":"Jahresbericht 2009: Stand der Drogenproblematik in Europa [in German]","author":"EBDD (Europ\u00e4ische Beobachtungsstelle f\u00fcr Drogen und Drogensucht)","year":"2009","unstructured":"EBDD (Europ\u00e4ische Beobachtungsstelle f\u00fcr Drogen und Drogensucht). 2009. Jahresbericht 2009: Stand der Drogenproblematik in Europa [in German]. Luxemburg: Amt f\u00fcr amtliche Ver\u00f6ffentlichungen der Europ\u00e4ischen Union."},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.08.024"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.12.1280"},{"key":"e_1_3_2_83_1","first-page":"289","article-title":"Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology","volume":"6","author":"Ehret GN","year":"2007","unstructured":"Ehret GN, Desmeules JA, Broers B 2007. Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology. Expert Opin Fas 6:289\u2013303.","journal-title":"Expert Opin Fas"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(97)01347-1"},{"key":"e_1_3_2_85_1","first-page":"257","article-title":"Kammertachykardien (\u201cTorsade de Pointes) und weitere Herzrhytmusst\u00f6rungen unter Methadonsubstitiution: Risikominderung durch Medikamentenumstellung [in German]","volume":"7","author":"Elsner H","year":"2005","unstructured":"Elsner H. 2005. Kammertachykardien (\u201cTorsade de Pointes) und weitere Herzrhytmusst\u00f6rungen unter Methadonsubstitiution: Risikominderung durch Medikamentenumstellung [in German]. Suchtmed 7:257\u2013263.","journal-title":"Suchtmed"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002208"},{"key":"e_1_3_2_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(01)00171-5"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550880903183042"},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550880903436010"},{"key":"e_1_3_2_90_1","volume-title":"The legislation, organisation and delivery of methadone in 12 EU member states","author":"Farrell M","year":"1996","unstructured":"Farrell M, Neeleman J, Gossop M, Griffiths P, Buning E, Finch E, . 1996. The legislation, organisation and delivery of methadone in 12 EU member states. Brussels: European Commission."},{"key":"e_1_3_2_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.06.003"},{"key":"e_1_3_2_92_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003410.pub3"},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897070109511459"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2007.05.003"},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01321.x"},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.1159\/000313335"},{"key":"e_1_3_2_97_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2000.00272.x"},{"key":"e_1_3_2_98_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2004.02079.x"},{"key":"e_1_3_2_99_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022164"},{"key":"e_1_3_2_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2004.03.002"},{"key":"e_1_3_2_101_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161210791516459"},{"key":"e_1_3_2_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2003.11.017"},{"key":"e_1_3_2_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(03)00906-8"},{"key":"e_1_3_2_104_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1M347"},{"key":"e_1_3_2_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.02.022"},{"key":"e_1_3_2_106_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1980.03300300021018"},{"key":"e_1_3_2_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(95)01205-2"},{"key":"e_1_3_2_108_1","first-page":"429","article-title":"Interactions between methadone and medications used to treat HIV infection: a review","volume":"67","author":"Gourevitch MN","year":"2000","unstructured":"Gourevitch MN, Friedland GH. 2000. Interactions between methadone and medications used to treat HIV infection: a review. Mt Sinai J Med 67:429\u2013436.","journal-title":"Mt Sinai J Med"},{"key":"e_1_3_2_109_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002025.pub3"},{"key":"e_1_3_2_110_1","article-title":"Alpha2-adrenergic agonists for the management of opioid withdrawal","author":"Gowing L","year":"2009","unstructured":"Gowing L, Farrell M, Ali R, White JM. 2009. Alpha2-adrenergic agonists for the management of opioid withdrawal. Cochrane Database Syst Rev:CD002024.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_111_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002022.pub3"},{"key":"e_1_3_2_112_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952997909001724"},{"key":"e_1_3_2_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(02)00231-1"},{"key":"e_1_3_2_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2007.01.008"},{"key":"e_1_3_2_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.04.043"},{"key":"e_1_3_2_116_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550490390226941"},{"key":"e_1_3_2_117_1","doi-asserted-by":"publisher","DOI":"10.1037\/1064-1297.14.2.148"},{"key":"e_1_3_2_118_1","doi-asserted-by":"publisher","DOI":"10.1037\/1064-1297.14.2.157"},{"key":"e_1_3_2_119_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-010-0048-2"},{"key":"e_1_3_2_120_1","doi-asserted-by":"publisher","DOI":"10.1080\/15622970902823202"},{"key":"e_1_3_2_121_1","first-page":"569","volume-title":"The Pharmacological Basis of Therapeutics","author":"Gutstein HB","year":"2001","unstructured":"Gutstein HB, Akil H 2001. Opioid analgesics. in: Goodman and Gilman's. The Pharmacological Basis of Therapeutics, 10th. Hardman JG, Limbirg LE, Gilman AG. New York: McGraw-Hill. 569\u2013620.","edition":"10"},{"key":"e_1_3_2_122_1","doi-asserted-by":"publisher","DOI":"10.1080\/00952990802122564"},{"key":"e_1_3_2_123_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-009-9465-9"},{"key":"e_1_3_2_124_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.106.026112"},{"key":"e_1_3_2_125_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1980.01780210035003"},{"key":"e_1_3_2_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2008.07.002"},{"key":"e_1_3_2_127_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1M161"},{"key":"e_1_3_2_128_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.58.5.503"},{"key":"e_1_3_2_129_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1997.tb02877.x"},{"key":"e_1_3_2_130_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1998.93710338.x"},{"key":"e_1_3_2_131_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1999.9422216.x"},{"key":"e_1_3_2_132_1","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2009.130"},{"key":"e_1_3_2_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2010.04.003"},{"key":"e_1_3_2_134_1","doi-asserted-by":"publisher","DOI":"10.1037\/1064-1297.4.3.315"},{"key":"e_1_3_2_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2005.04.001"},{"key":"e_1_3_2_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(94)90096-5"},{"key":"e_1_3_2_137_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.09.64"},{"key":"e_1_3_2_138_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1985.01790340041006"},{"key":"e_1_3_2_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(03)00062-0"},{"key":"e_1_3_2_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4603(98)00119-1"},{"key":"e_1_3_2_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(00)00152-6"},{"key":"e_1_3_2_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.11.013"},{"key":"e_1_3_2_143_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2007.10.007"},{"key":"e_1_3_2_144_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1976204445"},{"issue":"2288","key":"e_1_3_2_145_1","first-page":"2289","article-title":"Methadone-induced long QT syndrome vs methadone-induced torsades de pointes","volume":"166","author":"Justo D","year":"2006","unstructured":"Justo D. 2006. Methadone-induced long QT syndrome vs methadone-induced torsades de pointes. Arch Intern Med 166:2288; author reply 2289\u20132290.","journal-title":"Arch Intern Med"},{"key":"e_1_3_2_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12600-1"},{"key":"e_1_3_2_147_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2007.164.5.797"},{"key":"e_1_3_2_148_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.01.025"},{"key":"e_1_3_2_149_1","first-page":"5","article-title":"Buprenorphine-naloxone versus methadone maintenance therapy: a randomised double-blind trial with opioid-dependent patients","volume":"10","author":"Kamien JB","year":"2008","unstructured":"Kamien JB, Branstetter SA, Amass L. 2008. Buprenorphine-naloxone versus methadone maintenance therapy: a randomised double-blind trial with opioid-dependent patients. Heroin Addict Relat Clin Probl 10:5\u201318.","journal-title":"Heroin Addict Relat Clin Probl"},{"key":"e_1_3_2_150_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0095-5108(18)30077-0"},{"key":"e_1_3_2_151_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02334.x"},{"key":"e_1_3_2_152_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.05.002"},{"key":"e_1_3_2_153_1","volume-title":"Addiction and the vulnerable self: Modified dynamic group therapy for substance abusers","author":"Khantzian EJ","year":"1990","unstructured":"Khantzian EJ, Halliday KS, MacAuliffe WE. 1990. Addiction and the vulnerable self: Modified dynamic group therapy for substance abusers. New York: Guilford."},{"key":"e_1_3_2_154_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.05.003"},{"key":"e_1_3_2_155_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c3172"},{"key":"e_1_3_2_156_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1985.01790270081009"},{"key":"e_1_3_2_157_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952998709001497"},{"key":"e_1_3_2_158_1","first-page":"5","article-title":"Treatment of patients with substance use disorders, second edition","volume":"164","author":"Kleber HD","year":"2007","unstructured":"Kleber HD, Weiss RD, Anton RF Jr, George TP, Greenfield SF, Kosten TR, . 2007. Treatment of patients with substance use disorders, second edition. Am J Psychiatry 164:5\u2013123.","journal-title":"Am J Psychiatry"},{"key":"e_1_3_2_159_1","volume-title":"Neurobiology of addiction","author":"Koob GF","year":"2006","unstructured":"Koob GF, Le Moal M 2006. Neurobiology of addiction. Amsterdam: Academic Press."},{"key":"e_1_3_2_160_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952998609083739"},{"key":"e_1_3_2_161_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1987.01800150101012"},{"key":"e_1_3_2_162_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.147.10.1379b"},{"key":"e_1_3_2_163_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952999009001594"},{"key":"e_1_3_2_164_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-0571"},{"key":"e_1_3_2_165_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69173-3"},{"key":"e_1_3_2_166_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-6-200209170-00010"},{"key":"e_1_3_2_167_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.23.6.802.32186"},{"key":"e_1_3_2_168_1","doi-asserted-by":"publisher","DOI":"10.1300\/J069v26n04_10"},{"key":"e_1_3_2_169_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-6-200903170-00103"},{"key":"e_1_3_2_170_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1982.tb39489.x"},{"key":"e_1_3_2_171_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(79)90343-6"},{"key":"e_1_3_2_172_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199606000-00001"},{"key":"e_1_3_2_173_1","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0b013e3283386578"},{"key":"e_1_3_2_174_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(89)90088-5"},{"key":"e_1_3_2_175_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.91.5.774"},{"key":"e_1_3_2_176_1","doi-asserted-by":"publisher","DOI":"10.1080\/02699050210128915"},{"key":"e_1_3_2_177_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00236.x"},{"key":"e_1_3_2_178_1","doi-asserted-by":"publisher","DOI":"10.3109\/10550499709137021"},{"key":"e_1_3_2_179_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1976.01770060043007"},{"key":"e_1_3_2_180_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1996.01830050035005"},{"key":"e_1_3_2_181_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.01154.x"},{"key":"e_1_3_2_182_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1427"},{"key":"e_1_3_2_183_1","doi-asserted-by":"publisher","DOI":"10.1177\/026988110401800321"},{"key":"e_1_3_2_184_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006140.pub2"},{"key":"e_1_3_2_185_1","doi-asserted-by":"publisher","DOI":"10.1080\/00952990802308239"},{"key":"e_1_3_2_186_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2004.12.006"},{"key":"e_1_3_2_187_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2009.02653.x"},{"key":"e_1_3_2_188_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656560903213405"},{"key":"e_1_3_2_189_1","doi-asserted-by":"publisher","DOI":"10.36076\/ppj.2010\/13\/401"},{"key":"e_1_3_2_190_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61420-3"},{"key":"e_1_3_2_191_1","first-page":"29","article-title":"Methadone dose and retention in treatment of heroin addicts with bipolar I disorder comorbidity: preliminary results","volume":"2","author":"Maremmani I","year":"2000","unstructured":"Maremmani I, Canoniero S, Pacini M. 2000a. Methadone dose and retention in treatment of heroin addicts with bipolar I disorder comorbidity: preliminary results. Heroin Addict Relat Clin Prob 2:29\u201346.","journal-title":"Heroin Addict Relat Clin Prob"},{"key":"e_1_3_2_192_1","doi-asserted-by":"publisher","DOI":"10.1300\/J069v19n02_03"},{"key":"e_1_3_2_193_1","doi-asserted-by":"publisher","DOI":"10.1159\/000081416"},{"key":"e_1_3_2_194_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.11.055"},{"key":"e_1_3_2_195_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00335.x"},{"key":"e_1_3_2_196_1","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick RP","year":"2003","unstructured":"Mattick RP, Kimber J, Breen C, Davoli M. 2003b. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev:CD002207.","journal-title":"Cochrane Database Syst"},{"key":"e_1_3_2_197_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002209.pub2"},{"key":"e_1_3_2_198_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.09.006"},{"key":"e_1_3_2_199_1","first-page":"5","article-title":"Correlation between Hepatitis C serostatus and methadone dose requirement in 1,163 methadone-maintained patients","volume":"4","author":"Maxwell S","year":"2002","unstructured":"Maxwell S, Shinderman M, Miner A, Bennet A. 2002. Correlation between Hepatitis C serostatus and methadone dose requirement in 1,163 methadone-maintained patients. Heroin Addict Relat Clin Prob 4:5\u201310.","journal-title":"Heroin Addict Relat Clin Prob"},{"key":"e_1_3_2_200_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2009.00005.x"},{"key":"e_1_3_2_201_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2225"},{"key":"e_1_3_2_202_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03500150065028"},{"key":"e_1_3_2_203_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.12.008"},{"key":"e_1_3_2_204_1","doi-asserted-by":"publisher","DOI":"10.2165\/00139709-200625020-00002"},{"key":"e_1_3_2_205_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2010.01.006"},{"key":"e_1_3_2_206_1","first-page":"29","article-title":"Medical Recommendations for maintenance therapy in opioid dependence (Swiss Society of Addiction Medicine, in German)","volume":"10","author":"Meili D","year":"2008","unstructured":"Meili D, Broers B, Bruggmann, Fink A, H\u00e4mmig R. 2008. Medical Recommendations for maintenance therapy in opioid dependence (Swiss Society of Addiction Medicine, in German). Suchtmed 10:29\u201353.","journal-title":"Suchtmed"},{"key":"e_1_3_2_207_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(25)32374-8"},{"key":"e_1_3_2_208_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.1050"},{"key":"e_1_3_2_209_1","first-page":"5","article-title":"Effects of opioid pharmacotherapy on psychomotor and cognitive performance: A review of human laboratory studies of methadone and buprenorphine","volume":"9","author":"Mintzer MZ","year":"2007","unstructured":"Mintzer MZ. 2007. Effects of opioid pharmacotherapy on psychomotor and cognitive performance: A review of human laboratory studies of methadone and buprenorphine. Heroin Addict Relat Clin Prob 9:5\u201324.","journal-title":"Heroin Addict Relat Clin Prob"},{"key":"e_1_3_2_210_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(02)00013-3"},{"key":"e_1_3_2_211_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.10.008"},{"key":"e_1_3_2_212_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(03)00190-X"},{"key":"e_1_3_2_213_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2004.00764.x"},{"key":"e_1_3_2_214_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550880903014767"},{"key":"e_1_3_2_215_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2003.09.004"},{"key":"e_1_3_2_216_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600710110"},{"key":"e_1_3_2_217_1","volume-title":"Drug misuse, psychosocial interventions","author":"National Institute for Health and Clinical Excellence","year":"2007","unstructured":"National Institute for Health and Clinical Excellence. 2007a. Drug misuse, psychosocial interventions. NICE Clinical Guideline 51, London."},{"key":"e_1_3_2_218_1","volume-title":"Drug misuse, Opioid detoxification","author":"National Institute for Health and Clinical Excellence","year":"2007","unstructured":"National Institute for Health and Clinical Excellence. 2007b. Drug misuse, Opioid detoxification. NICE Clinical Guideline 52, London."},{"key":"e_1_3_2_219_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1978.01770270085008"},{"key":"e_1_3_2_220_1","doi-asserted-by":"publisher","DOI":"10.1080\/10826080600846235"},{"key":"e_1_3_2_221_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.65.4.457"},{"key":"e_1_3_2_222_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2010.16.S1-B.14"},{"key":"e_1_3_2_223_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02385.x"},{"key":"e_1_3_2_224_1","doi-asserted-by":"publisher","DOI":"10.1016\/0740-5472(93)90024-V"},{"key":"e_1_3_2_225_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(98)00194-6"},{"key":"e_1_3_2_226_1","first-page":"57","article-title":"Hepatitis C infected patients and higher doses of methadone","volume":"2","author":"Okruhlica L","year":"2000","unstructured":"Okruhlica L, Klempova D. 2000. Hepatitis C infected patients and higher doses of methadone. Heroin Addict Relat Clin Prob 2:57\u201358.","journal-title":"Heroin Addict Relat Clin Prob"},{"key":"e_1_3_2_227_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.07.008"},{"key":"e_1_3_2_228_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200969050-00006"},{"key":"e_1_3_2_229_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810635"},{"key":"e_1_3_2_230_1","doi-asserted-by":"publisher","DOI":"10.1093\/arclin\/17.7.663"},{"key":"e_1_3_2_231_1","doi-asserted-by":"publisher","DOI":"10.1300\/J069v25n02_06"},{"key":"e_1_3_2_232_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01668.x"},{"key":"e_1_3_2_233_1","article-title":"QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France","author":"Perrin-Terrin A","year":"2010","unstructured":"Perrin-Terrin A, Pathak A, Lapeyre-Mestre M. 2010. QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France. Fundam Clin Pharmacol (in press).","journal-title":"Fundam Clin Pharmacol"},{"key":"e_1_3_2_234_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826080903442836"},{"key":"e_1_3_2_235_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(00)00163-0"},{"key":"e_1_3_2_236_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(99)70039-1"},{"key":"e_1_3_2_237_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2000.95710698.x"},{"key":"e_1_3_2_238_1","first-page":"66","article-title":"Naltrexone hydrochloride (Trexan): a review of serum transaminase elevations at high dosage","volume":"67","author":"Pfohl DN","year":"1986","unstructured":"Pfohl DN, Allen JI, Atkinson RL, Knopman DS, Malcolm RJ, Mitchell JE, . 1986. Naltrexone hydrochloride (Trexan): a review of serum transaminase elevations at high dosage. NIDA Res Monogr 67:66\u201372.","journal-title":"NIDA Res Monogr"},{"key":"e_1_3_2_239_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.11.008"},{"key":"e_1_3_2_240_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2004.00790.x"},{"key":"e_1_3_2_241_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826080009148246"},{"key":"e_1_3_2_242_1","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.69.3.389"},{"key":"e_1_3_2_243_1","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(90)90136-3"},{"key":"e_1_3_2_244_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(98)00152-5"},{"key":"e_1_3_2_245_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.02.006"},{"key":"e_1_3_2_246_1","doi-asserted-by":"publisher","DOI":"10.1186\/1747-597X-2-35"},{"key":"e_1_3_2_247_1","doi-asserted-by":"publisher","DOI":"10.2174\/157488406775268219"},{"key":"e_1_3_2_248_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881107078308"},{"key":"e_1_3_2_249_1","article-title":"Acamprosate for alcohol dependence","volume":"8","author":"R\u00f6sner S","year":"2010","unstructured":"R\u00f6sner S, Hackl-Herrwerth A, Leucht S, Lehert P, Vecchi S, Soyka M. 2010. Acamprosate for alcohol dependence. Cochrane Database Syst Rev 8: CD004332.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_250_1","unstructured":"SAMHSA (Substance Abuse and Mental Health Services Administration). 2001. National Household Survey on Drug Abuse (NHSDA) [http:\/\/www.samhsa.gov]."},{"key":"e_1_3_2_251_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826081003791932"},{"key":"e_1_3_2_252_1","doi-asserted-by":"publisher","DOI":"10.1159\/000104886"},{"key":"e_1_3_2_253_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-979573"},{"key":"e_1_3_2_254_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1997.01830200041006"},{"key":"e_1_3_2_255_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.10.1303"},{"key":"e_1_3_2_256_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-34115"},{"key":"e_1_3_2_257_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7183.593"},{"key":"e_1_3_2_258_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1996.01830050045007"},{"key":"e_1_3_2_259_1","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.66.5.811"},{"key":"e_1_3_2_260_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2008.10.012"},{"key":"e_1_3_2_261_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0640-8"},{"key":"e_1_3_2_262_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100095"},{"key":"e_1_3_2_263_1","first-page":"7","article-title":"Safety issues in methadone maintenance, part 1: Legal basis, mortality, and clinical results (in German)","volume":"10","author":"Soyka M","year":"2008","unstructured":"Soyka M. 2008a. Safety issues in methadone maintenance, part 1: Legal basis, mortality, and clinical results (in German). Suchtmed 10:7\u201327.","journal-title":"Suchtmed"},{"key":"e_1_3_2_264_1","first-page":"119","article-title":"Safety issues in methadone maintenance therapy, part 2: Clinical and pharmacological aspects. (in German)","volume":"10","author":"Soyka M","year":"2008","unstructured":"Soyka M. 2008b. Safety issues in methadone maintenance therapy, part 2: Clinical and pharmacological aspects. (in German). Suchtmed 10:119\u2013144.","journal-title":"Suchtmed"},{"key":"e_1_3_2_265_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728214.2010.500811"},{"key":"e_1_3_2_266_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2010.522990"},{"key":"e_1_3_2_267_1","doi-asserted-by":"publisher","DOI":"10.1080\/15622970802416057"},{"key":"e_1_3_2_268_1","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.13.4.527"},{"key":"e_1_3_2_269_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000178417.60426.60"},{"key":"e_1_3_2_270_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000245561.99036.49"},{"key":"e_1_3_2_271_1","doi-asserted-by":"publisher","DOI":"10.1080\/15622970801896390"},{"key":"e_1_3_2_272_1","doi-asserted-by":"publisher","DOI":"10.1017\/S146114570700836X"},{"key":"e_1_3_2_273_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(98)00106-9"},{"key":"e_1_3_2_274_1","doi-asserted-by":"publisher","DOI":"10.1159\/000019004"},{"key":"e_1_3_2_275_1","doi-asserted-by":"publisher","DOI":"10.1016\/0740-5472(89)90038-X"},{"key":"e_1_3_2_276_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550880902772431"},{"key":"e_1_3_2_277_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.140.7.862"},{"key":"e_1_3_2_278_1","doi-asserted-by":"publisher","DOI":"10.3109\/10550499208993149"},{"key":"e_1_3_2_279_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000644"},{"key":"e_1_3_2_280_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(01)01292-6"},{"key":"e_1_3_2_281_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826087809039299"},{"key":"e_1_3_2_282_1","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(86)90097-9"},{"key":"e_1_3_2_283_1","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.60.6.927"},{"key":"e_1_3_2_284_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000637"},{"key":"e_1_3_2_285_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656560903037168"},{"key":"e_1_3_2_286_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-119-1-199307010-00004"},{"key":"e_1_3_2_287_1","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(93)90052-R"},{"key":"e_1_3_2_288_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.7.1025"},{"key":"e_1_3_2_289_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.11.1000"},{"key":"e_1_3_2_290_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2009.15.7.556"},{"key":"e_1_3_2_291_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp070392"},{"key":"e_1_3_2_292_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2000.951116314.x"},{"key":"e_1_3_2_293_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60349-2"},{"key":"e_1_3_2_294_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826088409057176"},{"key":"e_1_3_2_295_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0509-x"},{"key":"e_1_3_2_296_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2007.08.014"},{"key":"e_1_3_2_297_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwi035"},{"key":"e_1_3_2_298_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550490500528712"},{"key":"e_1_3_2_299_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1998.93226910.x"},{"key":"e_1_3_2_300_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2009.02741.x"},{"key":"e_1_3_2_301_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550881003684814"},{"key":"e_1_3_2_302_1","doi-asserted-by":"publisher","DOI":"10.18356\/1f8caff1-en"},{"key":"e_1_3_2_303_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(02)00325-3"},{"key":"e_1_3_2_304_1","doi-asserted-by":"publisher","DOI":"10.2174\/157488408784293679"},{"key":"e_1_3_2_305_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674370605101003"},{"key":"e_1_3_2_306_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2003.08.008"},{"key":"e_1_3_2_307_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.6.2.125"},{"key":"e_1_3_2_308_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.11.006"},{"key":"e_1_3_2_309_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02185.x"},{"key":"e_1_3_2_310_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02246290"},{"key":"e_1_3_2_311_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(80)91515-9"},{"key":"e_1_3_2_312_1","doi-asserted-by":"publisher","DOI":"10.1300\/J251v04n02_08"},{"key":"e_1_3_2_313_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-010-1825-8"},{"key":"e_1_3_2_314_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02410.x"},{"key":"e_1_3_2_315_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2010.10400689"},{"key":"e_1_3_2_316_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-3289(01)00054-2"},{"key":"e_1_3_2_317_1","doi-asserted-by":"publisher","DOI":"10.1016\/0740-5472(93)90056-8"},{"key":"e_1_3_2_318_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02283.x"},{"key":"e_1_3_2_319_1","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0b013e3282fb25e5"},{"key":"e_1_3_2_320_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.01.015"},{"key":"e_1_3_2_321_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2008.02.008"},{"key":"e_1_3_2_322_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1983.04390010049006"},{"key":"e_1_3_2_323_1","first-page":"23","article-title":"Treatment of behavioral and psychiatric problems associated with opiate dependence","volume":"46","author":"Woody GE","year":"1984","unstructured":"Woody GE, McLellan AT, O'Brien CP. 1984. Treatment of behavioral and psychiatric problems associated with opiate dependence. NIDA Res Monogr 46:23\u201335.","journal-title":"NIDA Res Monogr"},{"key":"e_1_3_2_324_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.144.5.590"},{"key":"e_1_3_2_325_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.152.9.1302"},{"key":"e_1_3_2_326_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2008.574"},{"key":"e_1_3_2_327_1","doi-asserted-by":"publisher","DOI":"10.30875\/b469a751-en"},{"key":"e_1_3_2_328_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.alcohol.2006.05.003"},{"key":"e_1_3_2_329_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.05275.x"},{"key":"e_1_3_2_330_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.06.016"},{"key":"e_1_3_2_331_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(82)90811-3"}],"container-title":["The World Journal of Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/15622975.2011.561872","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T12:27:04Z","timestamp":1772713624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/15622975.2011.561872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":330,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["10.3109\/15622975.2011.561872"],"URL":"https:\/\/doi.org\/10.3109\/15622975.2011.561872","relation":{},"ISSN":["1562-2975","1814-1412"],"issn-type":[{"value":"1562-2975","type":"print"},{"value":"1814-1412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}